High expression of Ki-67 has been significantly associated with more aggressive cancer features, such as lymph node metastasis, tumor invasion, high tumor nuclear grade, clinical stage, adverse survival outcomes, and failure to achieve a pathological complete response in TNBC patients [41]. Here, MKI67 is linked to cancer.